CAS 475110-96-4
:2-(Difluoromethyl)-1-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-1H-benzimidazole
Description:
2-(Difluoromethyl)-1-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-1H-benzimidazole is a chemical compound characterized by its complex structure, which includes a benzimidazole core and a triazine moiety. The presence of difluoromethyl groups suggests that it may exhibit unique electronic properties and reactivity due to the electronegative fluorine atoms. The morpholine groups contribute to its potential solubility and interaction with biological systems, making it of interest in pharmaceutical applications. This compound may possess specific biological activities, potentially acting as a herbicide or fungicide, given its structural features that are often associated with agrochemical properties. Its molecular weight, solubility, and stability under various conditions would be critical for its practical applications. Additionally, the compound's synthesis and purification methods would be essential for obtaining it in a usable form for research or industrial purposes. Safety data, including toxicity and environmental impact, would also be important considerations for handling and application.
Formula:C19H21F2N7O2
InChI:InChI=1S/C19H21F2N7O2/c20-15(21)16-22-13-3-1-2-4-14(13)28(16)19-24-17(26-5-9-29-10-6-26)23-18(25-19)27-7-11-30-12-8-27/h1-4,15H,5-12H2
InChI key:InChIKey=HGVNLRPZOWWDKD-UHFFFAOYSA-N
SMILES:C(F)(F)C=1N(C=2C(N1)=CC=CC2)C=3N=C(N=C(N3)N4CCOCC4)N5CCOCC5
Synonyms:- 1H-Benzimidazole, 2-(difluoromethyl)-1-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-
- 2-(2-Difluoromethylbenzimidazol-1-yl)-4,6-bis(morpholino)-1,3,5-triazine
- 2-(2-Difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine
- 2-(Difluoromethyl)-1-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-1H-benzimidazole
- Tcmdc-137004
- Zstk 474
- Zstk474
- 4,4′-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
4,4'-(6-(2-(Difluoromethyl)-1H-Benzo[D]Imidazol-1-Yl)-1,3,5-Triazine-2,4-Diyl)Dimorpholine
CAS:<p>4,4'-(6-(2-(Difluoromethyl)-1H-Benzo[D]Imidazol-1-Yl)-1,3,5-Triazine-2,4-Diyl)Dimorpholine</p>Purity:98%Molecular weight:417.41g/molZSTK474
CAS:<p>PI3K Inhibitor ZSTK474 is an orally available, s-triazine derivative, ATP-competitive phosphatidylinositol 3-kinase (PI3K) inhibitor with potential</p>Formula:C19H21F2N7O2Purity:98.29% - 99.95%Color and Shape:White PowderMolecular weight:417.41ZSTK 474
CAS:Controlled Product<p>Applications ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase (PI3K) isoforms. Potent PI3K inhibitor.<br>References Yaguchi, S., et al.: J. Natl. Cancer Inst., 98, 545 (2006); Kong, D., et al.: Cancer Sci., 98, 1638 (2007); Kong, D., et al.: Eur. J. Cancer, 45, 857 (2009); Marone, R., et al.: Mol. Cancer Res., 7, 601 (2009); Yang, S., et al.: PLoS One, 6, e26343 (2011); Haruta, K., et al.: Inflamm, Res., 61, 551 (2012);<br></p>Formula:C19H21F2N7O2Color and Shape:NeatMolecular weight:417.41ZSTK474
CAS:<p>ZSTK474 is a novel compound that has been shown to have autophagy-inducing properties. Studies have found that ZSTK474 inhibits the growth of human cancer cells in vitro and in vivo, and also has inhibitory effects on epithelial mesenchymal transition (EMT) and metastasis. ZSTK474 targets the mitochondrial membrane potential and ATP production, which reduces cellular energy metabolism. These inhibitory effects lead to increased autophagy in cells, which may be due to the inhibition of protein synthesis and cell cycle progression. ZSTK474 has also been shown to induce apoptosis in cancer cells by inducing DNA damage.</p>Formula:C19H21O2N7F2Purity:Min. 95%Molecular weight:417.17248






